Jefferies Group’s Maravai LifeSciences MRVI Stock Holding History

Jefferies Group’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$653K	Buy	+25,586	New	+$642K	0.01%	944
2021 Q4	–	Sell	-47,974	Closed	-$2.35M	–	1877
2021 Q3	$2.35M	Buy	47,974 +27,774	+137%	+$1.35M	0.02%	708
2021 Q2	$843K	Buy	+20,200	New	+$783K	0.01%	1040
2021 Q1	–	Sell	-80,520	Closed	-$2.26M	–	1856
2020 Q4	$2.26M	Buy	+80,520	New	+$2.24M	0.02%	668

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Jefferies Group's MRVI Position: Q3 2022 in Review

Jefferies Group opened a new position in Maravai LifeSciences (MRVI) in Q3 2022: 25,586 shares worth $653K. The stake represents 0.01% of the portfolio and ranks #944 among its holdings. This is a return to the name: Jefferies Group previously reported a position in MRVI as recently as Q3 2021.

Jefferies Group first reported a position in MRVI in Q4 2020 and has held it in 4 quarters since. The position peaked at $2.35M in Q3 2021. 202 funds tracked by Wall St. Rank hold MRVI as of Q3 2022.

Jefferies Group held 25,586 shares of Maravai LifeSciences worth $653K as of Q3 2022.
Maravai LifeSciences was a new Jefferies Group position in Q3 2022.
Maravai LifeSciences made up 0.01% of Jefferies Group's portfolio in Q3 2022, its #944 holding.
Jefferies Group first reported a position in Maravai LifeSciences in Q4 2020 and has held it in 4 quarters since.
Jefferies Group's Maravai LifeSciences position peaked at $2.35M in Q3 2021.
202 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.